Drug-carrier potential of liposomes in cancer chemotherapy.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008081:Liposomes / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy; D008247:Lysosomes / Q000378:metabolism; D008854:Microscopy, Electron; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014677:Pharmaceutical Vehicles; D012711:Serum Albumin, Radio-Iodinated; D014238:Trichloroacetic Acid / Q000097:blood; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D008081:Liposomes; D014677:Pharmaceutical Vehicles; D012711:Serum Albumin, Radio-Iodinated; D014238:Trichloroacetic Acid